Wiskott-Aldrich syndrome: Long-term results of gene therapy developed | HappeningNow.news

Health

Wiskott-Aldrich syndrome: Long-term results of gene therapy developed

A single infusion of genetically corrected autologous hematopoietic stem cells can provide lasting clinical benefits for patients with Wiskott-Aldrich syndrome, a rare genetic disorder that impairs immune and platelet function, exposing…

Source AI Summary Published 55m ago Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views New Be the first to read
Brief read Under 1 min brief 39 words

AI Summary

A single infusion of genetically corrected autologous hematopoietic stem cells can deliver lasting clinical benefits for children with Wiskott‑Aldrich syndrome, a rare disorder that compromises immune and platelet function and leads to early‑onset infections, bleeding, eczema and autoimmune complications.

AI summaries can be wrong sometimes—always verify important details using the source article.

How AI & Automation are used
Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page